搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Methanocorpusculum labreanum Translation initiation factor 6 (eif6) CSB-YP384819MNT
CSB-EP384819MNT
CSB-BP384819MNT
CSB-MP384819MNT
CSB-EP384819MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum Ribonuclease P protein component 4 (rnp4) CSB-YP384820MNT
CSB-EP384820MNT
CSB-BP384820MNT
CSB-MP384820MNT
CSB-EP384820MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum 30S ribosomal protein S8e (rps8e) CSB-YP384821MNT
CSB-EP384821MNT
CSB-BP384821MNT
CSB-MP384821MNT
CSB-EP384821MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum L-tyrosine decarboxylase (mfnA) CSB-YP384822MNT
CSB-EP384822MNT
CSB-BP384822MNT
CSB-MP384822MNT
CSB-EP384822MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum 50S ribosomal protein L1P (rpl1p) CSB-YP384823MNT
CSB-EP384823MNT
CSB-BP384823MNT
CSB-MP384823MNT
CSB-EP384823MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum D-tyrosyl-tRNA (Tyr) deacylase CSB-YP384824MNT
CSB-EP384824MNT
CSB-BP384824MNT
CSB-MP384824MNT
CSB-EP384824MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum Hydroxyethylthiazole kinase (thiM) CSB-YP384825MNT
CSB-EP384825MNT
CSB-BP384825MNT
CSB-MP384825MNT
CSB-EP384825MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum Tyrosine--tRNA ligase (tyrS) CSB-YP384826MNT
CSB-EP384826MNT
CSB-BP384826MNT
CSB-MP384826MNT
CSB-EP384826MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vicia sativa subsp. nigra Vicianin hydrolase CSB-YP384827VEC
CSB-EP384827VEC
CSB-BP384827VEC
CSB-MP384827VEC
CSB-EP384827VEC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydomonas reinhardtii Intraflagellar transport protein 46 (IFT46) CSB-YP384828DSJ
CSB-EP384828DSJ
CSB-BP384828DSJ
CSB-MP384828DSJ
CSB-EP384828DSJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Angiopteris evecta ATP synthase subunit a, chloroplastic (atpI), partial CSB-YP384829AUU1
CSB-EP384829AUU1
CSB-BP384829AUU1
CSB-MP384829AUU1
CSB-EP384829AUU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Angiopteris evecta Photosystem II D2 protein (psbD), partial CSB-YP384830AUU1
CSB-EP384830AUU1
CSB-BP384830AUU1
CSB-MP384830AUU1
CSB-EP384830AUU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Angiopteris evecta 30S ribosomal protein S4, chloroplastic (rps4) CSB-YP384831AUU
CSB-EP384831AUU
CSB-BP384831AUU
CSB-MP384831AUU
CSB-EP384831AUU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Angiopteris evecta Photosystem II reaction center protein J (psbJ), partial CSB-YP384832AUU
CSB-EP384832AUU
CSB-BP384832AUU
CSB-MP384832AUU
CSB-EP384832AUU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Angiopteris evecta Cytochrome b6-f complex subunit 5 (petG), partial CSB-YP384833AUU
CSB-EP384833AUU
CSB-BP384833AUU
CSB-MP384833AUU
CSB-EP384833AUU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Angiopteris evecta 50S ribosomal protein L33, chloroplastic (rpl33) CSB-YP384834AUU
CSB-EP384834AUU
CSB-BP384834AUU
CSB-MP384834AUU
CSB-EP384834AUU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Angiopteris evecta 50S ribosomal protein L20, chloroplastic (rpl20) CSB-YP384835AUU
CSB-EP384835AUU
CSB-BP384835AUU
CSB-MP384835AUU
CSB-EP384835AUU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Angiopteris evecta Photosystem II CP47 chlorophyll apoprotein (psbB), partial CSB-YP384836AUU1
CSB-EP384836AUU1
CSB-BP384836AUU1
CSB-MP384836AUU1
CSB-EP384836AUU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Angiopteris evecta 50S ribosomal protein L36, chloroplastic (rpl36) CSB-YP384837AUU
CSB-EP384837AUU
CSB-BP384837AUU
CSB-MP384837AUU
CSB-EP384837AUU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Angiopteris evecta 50S ribosomal protein L16, chloroplastic (rpl16) CSB-YP384838AUU
CSB-EP384838AUU
CSB-BP384838AUU
CSB-MP384838AUU
CSB-EP384838AUU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>